COYA coyatherapeutics.com: Bozor qiymatining balans qiymatiga nisbati
Neyrodegeneratsiya uchun dori vositalarini ishlab chiqish samaradorligi molekulyar xususiyatlarni saqlab qolish uchun biomateriallarning mukammal transportiga tayanadi. Coya Therapeutics, Inc. (COYA) kompaniyasining joriy biznes muvaffaqiyati ALS ga qarshi kurashish uchun T-hujayra usullarining sinov natijalariga va 2.14 miqdoridagi barqaror likvidlik zaxirasi bilan ta'minlangan sheriklik jadvallariga rioya qilishga bog'liq. GURU.Markets dagi ushbu aksiya kotirovlari grafigi Coya Therapeutics, Inc. (COYA) kompaniyasining inqilobiy terapevtik platformalar yaratishdagi innovator sifatidagi maqomini tasdiqlaydi.
Coya Therapeutics, Inc. (COYA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Coya Therapeutics, Inc.|COYA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati coyatherapeutics.com|COYA - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Coya|COYA - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Coya Therapeutics|Tezkor likvidlik ko‘rsatkichi coyatherapeutics.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Coya Therapeutics Inc - COYA
Ushbu koeffitsient pul oqimlari prizmasi orqali bozor baholangan qiymatining sof aktivlar sifatiga sezgirligini aks ettiradi. U investor kompaniyaning bir dollarli kapitali uchun necha sent bozor qiymatini to'lashga tayyorligini belgilaydi. Coya Therapeutics, Inc. (COYA) uchun ushbu muvozanat siklik ta'sirni bartaraf etuvchi uzoq muddatli grantlar va sog'liqni saqlash gigantlari bilan hamkorliklar orqali ta'minlanadi. Bozor qiymatining buxgalteriya qiymatiga nisbatidagi o'zgarishlarni tahlil qilish orqali T-hujayra terapiyalarining salohiyatiga bo'lgan ishonch darajasini baholash mumkin. Yuqori qiymatlar likvidlikni ko'rsatadi, ammo kelajakdagi daromadlarni cheklaydi.
Asosiy raqobatchilar
BIIB: Bozor kapitallashuvining balans qiymatiga nisbati|neurocrine.com (NBIX) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited|Kapitallashuvning balans qiymatiga nisbati AXSM (Axsome)|Bozor kapitallashuvining balans qiymatiga nisbati ACAD|XENE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Viking Therapeutics - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati supernus.com SUPN|CPRX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati DNLI (Denali)|Harmony Pharma (HRMY) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Biohaven Corp (BHVN)|AMLX (Amylyx Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati trevitherapeutics.com (TRVI)|Bozor qiymatining balans qiymatiga nisbati Praxis Precision Medicines, Inc. (PRAX)|AVXL - Bozor qiymatining balans qiymatiga koeffitsiyenti|CeriBell Corp - Kapitallashuvning sof aktivlarga nisbati|Prothena (PRTA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Alector Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|ANNX - Bozor kapitallashuvining balans qiymatiga nisbati|OMER (omeros.com) - Kapitallashuvning sof aktivlarga nisbati|Neurogene Inc - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati ACIU|VYGR (Voyager Corp) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati NMRA|SCLX (scilexholding.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TVGN (Tevogen Bio)|Alpha Cognition Inc (ACOG) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CGTX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati IKT (Inhibikase Pharma)|SAVA: Bozor kapitallashuvining balans qiymatiga nisbati|Assertio (ASRT) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati VistaGen Therapeutics, Inc.|Ovid Rx - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ABOS|CRVO - Bozor qiymatining balans qiymatiga koeffitsiyenti|Alterity Therapeutics Limited - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Clene Inc CLNN|PEPG: Kapitallashuvning sof aktivlarga nisbati|jupiterneurosciences.com - Bozor kapitallashuvining balans qiymatiga multiplikatori|RLMD: Bozor kapitallashuvining balans qiymatiga nisbati|ANVS - Balans qiymatiga nisbatan bozor kapitallashuvi|GRCE (Grace Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati fireflyneuro.com (AIFF)|Bozor qiymatining balans qiymatiga nisbati Klotho Neurosciences Inc (KLTO)|Balans qiymatiga nisbatan bozor kapitallashuvi neurosense-tx.com|Reviva Pharmaceuticals Holdings - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati MTVA|NeurAxis, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Helius Medical HSDT|passagebio.com (PASG) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati NEUP|NERV (Minerva Neurosciences Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Athira Pharma Corp (ATHA)|Kapitallashuvning sof aktivlarga nisbati ADXN (Addex Therapeutics)|Balans qiymatiga nisbatan bozor kapitallashuvi alzamend.com|Bozor kapitallashuvining balans qiymatiga nisbati CYCN (Cyclerion Therapeutics, Inc.)|PTIX - Kapitallashuvning sof aktivlarga nisbati|KTTA - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Cortigent, Inc.|ATXI (Avenue Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti brainstorm-cell.com (BCLI)|CARA (Cara Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Chromocell Therapeutics Corp|Bozor qiymatining balans qiymatiga nisbati Eliem Therapeutics (ELYM)|intracellulartherapies.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati LBPH (Longboard Pharmaceuticals)|marinuspharma.com (MRNS) - Bozor qiymatining balans qiymatiga koeffitsiyenti|NKGN: Kapitallashuvning sof aktivlarga nisbati|NRBO - Bozor kapitallashuvining balans qiymatiga nisbati|Sage Therapeutics, Inc (SAGE) - Bozor qiymatining balans qiymatiga nisbati|Synaptogenix, Inc - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Trevena, Inc.|Bozor qiymatining balans qiymatiga koeffitsiyenti Vigil Neuro VIGL|Bozor kapitallashuvining balans qiymatiga nisbati WENA|Kapitallashuvning sof aktivlarga nisbati Cerevel Therapeutics Inc CERE